Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAMERA: Metformin for Carotid Atherosclerosis
NCT00723307Phase 4Completed
- Start
- Feb 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs) in coronary artery disease (CAD). Started Feb 2009; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00723307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00723307.